The need for vigilance in extended criteria donors with a past history of malignancy: A case report and review of literature

Annals of Transplantation

Volumn 16, Issue 1, 2011, Pages 75-79

  Nickkholgh, Arash ^a   Frey, Erich ^b   Krenzel, Christoph ^b   Lauchart, Werner ^b   Flechtenmacher, Christa ^a   Schmidt, Jan ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Region Baden Württemberg ^*  (Germany)

Author keywords

Donor malignancy; Extended criteria donor; Liver transplantation; Serous adenocarcinoma of the ovary

Indexed keywords

ADULT; ARTICLE; BIOPSY TECHNIQUE; CANCER LOCALIZATION; CASE REPORT; FEMALE; HUMAN; LIVER TRANSPLANTATION; MEDICAL HISTORY; ORGAN DONOR; OVARY ADENOCARCINOMA;

CYSTADENOCARCINOMA, SEROUS; DONOR SELECTION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; OVARIAN NEOPLASMS; RISK FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSPLANTS;

EID: 79953279488     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schemmer P, Nickkholgh A, Hinz U et al: Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc, 2007; 39(2): 529-34
2. Buell JF, Beebe TM, Trofe J et al: Donor transmitted malignancies. Ann Transplant, 2004; 9(1): 53-56
3. Kauffman HM, Cherikh WS, McBride MA et al: Deceased donors with a past history of malignancy: an organ procurement and transplantation network/ united network for organ sharing update. Transplantation, 2007; 84: 272-74
4. Birkeland SA, Storm HH: Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation, 2002; 74(10): 1409-13
5. Kauffman HM, McBride MA, Cherikh WS et al: Transplant tumor registry: donor related malignancies. Transplantation, 2002; 74: 358-62
6. Frank S, Müller J, Bonk C et al: Transmission of glioblastoma multiforme through liver transplantation. Lancet, 1998; 352(9121): 31
7. Jonas S, Bechstein WO, Lemmens HP et al: Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int, 1996; 9(4): 426-29
8. Harbell JW, Dunn TB, Fauda M et al: Transmission of anaplastic large cell lymphoma via organ donation after cardiac death. Am J Transplant, 2008; 8(1): 238-44
9. Stephens JK, Everson GT, Elliott CL et al: Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation, 2000; 70(1): 232-36
10. Kim JK, Carmody IC, Cohen AJ, Loss GE: Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review. Clin Transplant, 2009; 23(4): 571-74
11. Cankovic M, Linden MD, Zarbo RJ: Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med, 2006; 130(4): 529-32
12. Morris-Stiff G, Steel A, Savage P et al: Welsh Transplantation Research Group. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant, 2004; 4(3): 444-46
13. Detry O, De Roover A, de Leval L et al: Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor. Liver Transpl, 2005; 11(6): 696-99
14. Donovan JA, Simmons FA, Esrason KT et al: Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation, 1997; 63(1): 80-84
15. Snape K, Izatt L, Ross P et al: Donor-transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: a rare indication for liver retransplantation. Liver Transpl, 2008; 14: 155-58
16. Lipshutz GS, Baxter-Lowe LA, Nguyen T et al: Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl, 2003; 9(10): 1102-7
17. Bodó I, Peters M, Radich JP et al: Donor-derived acute promyelocytic leukemia in a liver-transplant recipient. N Engl J Med, 1999; 341: 807-13
18. Feng S, Buell JF, Chari RS et al: Tumors and transplantation: The 2003 Third Annual ASTS State-ofthe-Art Winter Symposium. Am J Transplant, 2003; 3: 1481-67
19. MacKie RM, Reid R, Junor B: Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med, 2003; 348: 567-68
20. Lipshutz GS, Mihara N, Wong R et al: Death from metastatic donor-derived ovarian cancer in a male kidney transplant recipient. Am J Transplant, 2009; 9: 428-32
21. Penn I: Donor transmitted disease: cancer. Transplant Proc, 1991; 23: 2629-31
22. Hałoń A, Patrzałek D, Rabczyński J: Critical overview of the current status of organ donors with primary central nervous system tumors. Ann Transplant, 2002; 7(1): 6-14
23. Badia Castello M, Trujillano Cabello J, Serviá Goixart L et al: Occult donor metastatic adenocarcinoma. Contribution of the forensic autopsy. A case report. Ann Transplant, 2010; 15(1): 67-71